Ortho-k does not result in worsened vision or contrast sensitivity during the day that can significantly affect driving ...

Successfully solving this puzzle demands acute perception and unwavering focus on the minutiae. This serves as an ...

OCS-05 was well tolerated and improved vision and eye health in a Phase 2 trial in 33 people with optic neuritis due to MS or ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced the initiation of Part B of ...

GA management involves identifying at-risk patients, assessing visual function, and referring for treatment when necessary.